Afuco™ Anti-Human CXCL10 ADCC Therapeutic Antibody (NI-0801), ADCC Enhanced
Anti-CXCL10 ADCC Enhanced Antibody (NI-0801) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a fully human monoclonal antibody targeting the chemokine IP-10 (CXCL10) in healthy volunteers. The phase I study of escalating single intravenous doses of NI-0801 in healthy volunteers demonstrated that NI-0801 is well tolerated at doses up to and including 20mg/kg.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-188CL |
| Pricing | Inquiry |
| Host | Human |
| Target | CXCL10 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Can be stored at 4°C. For long term storage, aliquot and store at -20°C. Avoid repeated freezing and thawing cycles. |